Bioperfectus Monkeypox Virus PCR Kit to Support Testing Across Africa

Company news
2022-06-28

June 28, 2022, Shanghai, China— Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) Deputy General Manager Mr. TUNC MERT SAYIN addressed the opening ceremony of the Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique held by Africa Centers for Disease Control and Prevention (*hereinafter refer to as Africa CDC), African Union in collaboration with Nigeria Centre for Disease Control (Nigeria CDC) and African Society for Laboratory Medicine (ASLM).

 

 

With the monkeypox virus cases resurging globally, Africa CDC is actively working on highlighting the PCR technique diagnosis among member countries. The Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique is part of the Africa CDC daily routines, which aim to give technical training to the laboratorian professionals and enhance the local testing capacity against infectious diseases.

 

During the speech, Bioperfectus Deputy General Manager of International Sales & Marketing Division, Mr. TUNC MERT SAYIN, said, “As a response to the current Monkeypox outbreak, Bioperfectus delivered Monkeypox Virus Real Time PCR Kits to Africa CDC to be a supportive part of testing and tracing across the region. In the meantime, we would like to extend our appreciation to Africa CDC for having us for the opening speech of the valuable workshop.”

 

Bioperfectus, a public listed company on Shanghai Stock Exchange, is specialized in molecular diagnostics and has been providing infectious disease testing solutions since 2010. The world faces more threats and challenges of infectious diseases than ever. We have been actively providing solutions, increasing awareness, and empowering the knowledge and skills of frontline healthcare professionals globally.

 

View the full agenda of the workshop by clicking here>>

 


About Bioperfectus

 

Bioperfectus, a publicly listed company on Shanghai Stock Exchange (SSE:688399), has been a leading molecular diagnostic solution provider specializing in infectious diseases since 2010. With headquarters in Jiangsu, and subsidiaries in Shanghai, Beijing, Xi'an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in the molecular diagnostics market with our products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests, and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream of creating a healthier future for our next generations. For more information, please follow us on LinkedIn or visit www.bioperfectus.com.

 

About Africa CDC

 

Africa CDC is a specialized technical institution of the African Union established to support public health initiatives of Member States and strengthen the capacity of their public health institutions to detect, prevent, control, and respond quickly and effectively to disease threats. To learn more, please visit https://africacdc.org/

MOST READ

Your Problem, Our Solution

At Bioperfectus, the excellent experience of our customers is our goal and the key to our job. Last Wednesday, we completed online technical training for our distribution local support in the Asia Pacific region. The webinar covers insightful training on Bioperfectus Nucleic Acid Extraction System, Nucleic Acid Extraction Kit, Real-Time PCR System, and product demonstration on the newly launched SAW-96 Nucleic Acid Extraction Workstation.

2022-08-16

MHRA Registration Approval for BioPerfectus Monkeypox Virus Real Time PCR Kit

Jiangsu BioPerfectus Technologies Co., Ltd. (hereinafter referred to as “BioPerfectus”) is pleased to announce that Monkeypox Virus Real Time PCR Kit has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and is now officially available for Great Britain and Northern Ireland market.

2022-08-11

A Simplified HPV-DNA Workflow for Better Preventing Cervical Cancer

With over 600 thousand new cases and more than half that would lead to death each year, cervical cancer is listed as the fourth most frequent cancer among women worldwide.

2022-08-05